Gastrointestinal Medical Oncology Clinic

Pancreatic Cancer Early Detection Consortium

Diagnosis of PDAC

Recruiting

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Can...

Overall survival is defined as the time from randomization to death due to any cause. The median and 95% confidence intervals are estimated using the Kaplan-Meier estimator. The treatment arms will be compared using a stratified C...

Recruiting

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

The proportion of patients who achieve a greater than 50% decline from baseline prostate specific antigen (PSA) (PSA50) drawn prior to C1D1, at any point in the treatment course, will be descriptively reported along with 95% binom...

Recruiting

Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

ORR is defined as a complete response (CR) or a partial response (PR) according to RECIST version 1.1 criteria. The All Subjects as Treated (ASaT, ITT) population will be used for analysis which consists of all participants who re...

Recruiting

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Sensitivity of 18F-fluorocholine PET for the detection of abnormal parathyroid adenomas confirmed by pathology as compared to sestamibi imaging. Location of parathyroid adenoma at imaging as read by three blinded readers, will be ...

Recruiting

A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic ...

Recruiting

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

The overall percentage of participants with pathogenic, or likely pathogenic germline mutations will be reported with 95% confidence intervals

Recruiting

Fluoroethyltyrosine in Detecting Tumors in Participants With Recurrent Intracranial Tumors

Radiologists will classify lesions based on imaging as either having recurrent disease or not having recurrent disease. True Positives (TP) are defined as an FET PET read positive for tumor and pathology/follow-up demonstrates tum...

Recruiting

A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcino...

The percentage of subjects who experience a grade 3 or higher adverse event that qualifies as a DLT

Recruiting

Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers

The point estimation of proportion of patients who engaged with the ePRO tool via virtual care chat at least once after enrollment and its 95% binomial confidence interval (CI) will be obtained.

Recruiting